The goal of this clinical trial is to explore if a telehealth music therapy intervention helps with quality of life, depression symptoms, anxiety symptoms. It will also explore the participants' relationship to music. The main questions it aims to answer are:
* Refine and tailor the music therapy intervention to fit the specific needs of adults living with an autoimmune disease and depression. * Examine the feasibility of the study protocol to support a future full-scale trial * Examine how music therapy impacts quality of life, depression symptoms, and anxiety symptoms * Explore how music therapy impacts one's relationship to music
Participants will:
* have a short interview where you'll fill out a questionnaire with some basic information, answers about your depression, quality of life, and potential anxiety, and a question about how you feel about music at the start and end of the sessions * attend 8 weekly sessions, approximately 30-45 minutes each, with a board certified music therapist over telehealth/Zoom * answer a few questions about the music therapy intervention
self-reported depression
self-reported autoimmune endocrine disease
18-65 years of age
have a device that supports the Zoom platform (camera and audio)
intellectual or developmental disability
no auto-immune disease
no depression
lack of access to device
Appalachian State University
Lead sponsor
Meredith Wilson Foundation
Collaborator
University of North Carolina, Chapel Hill
Collaborator